Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer.


OBJECTIVES We sought to assess changes in antirestenotic efficacy of drug-eluting stents (DES) by restudying subjects at 2 time points after coronary stenting (6 to 8 months and 2 years) and to compare differences in time courses of late luminal loss (LLL) between 3 different DES platforms in use at our institution. BACKGROUND DES therapy is associated… (More)
DOI: 10.1016/j.jcin.2008.11.015


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics